Although metformin combination with anthracycline/taxane chemotherapy did not show significant improvement in the clinical and pathological tumor responses as well as the BCR of operable locally advanced BC, it was observed that all the outcomes were enhanced numerically in the metformin group compared to the control group. The gene discussed is BCR; the disease is neoplasm.